Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 1, 2001, Pages 25-29

  Felley, Christian P ^a   Corthésy Theulaz, Irène ^a   Rivero, Jose Luis Blanco ^a   Sipponen, Pentti ^b   Kaufmann, Martin ^c   Bauerfeind, Peter ^c   Wiesel, Paul H ^a   Brassart, Dominique ^d   Pfeifer, Andrea ^d   Blum, André L ^a   Michetti, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b JORVI HOSPITAL   (Finland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bacterial interference; Helicobacter pylori; Lactobacillus johnsonii

Indexed keywords

CLARITHROMYCIN;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENOSCOPY; ERADICATION THERAPY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS JOHNSONII; MAJOR CLINICAL STUDY; MALE; MILK; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; STOMACH BIOPSY;

ANIMALS; ANTI-BACTERIAL AGENTS; BREATH TESTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOBACILLUS ACIDOPHILUS; MALE; MILK; PYLORIC ANTRUM;

EID: 0035140016     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200101000-00005     Document Type: Article

References (33)

1. Blaser MJ, Crabtree JE. CagA and the outcome of Helicobacter pylori infection. Am J Clin Pathol 1996; 106: 565-567.
2. Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis 1996; 5: 191-202.
3. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-741.
4. Mobley HLT. Helicobacter pylori factors associated with disease development. Gastroenterology 1997; 113 (suppl 6): S21-S28.
5. Go MF. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997; 113 (suppl 6): S15-S20.
6. Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T. et al. Contribution of HLA-DQA gene to host’s response against Helicobacter pylori. Lancet 1994; 343: 542-543.
7. Heneghan MA, Moran AP, Feeley KM, Egan EL, Goulding J, Connolly CE. et al. Effect of host Lewis and ABO blood group antigen expression on Helicobacter pylori colonisation density and the consequent inflammatory response. FEMS Immunol Med Microbiol 1998; 20: 257-266.
8. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-489.
9. Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S. The human Lactobacillus acidophilus strain LA 1 secretes a nonbacteriotocin antibacterial substance(s) active in vitro and in vivo. Appl Env Microbiol 1997; 63: 2747-2753.
10. Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987; 70: 1-12.
11. Marteau P, Mikenus M, Havenaar R, Huisinít Veld JH. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 1997; 80: 1031-1037.
12. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989; 27: 2328-2330.
13. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M. et al. The effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 203-209.
14. Logan RP, Polson RJ, Misiewicz JJ, Rao G, Karim NQ, Newell D. et al. Simplified single sample 13 carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut 1991; 32: 1461-1464.
15. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-222.
16. Stolte M, Stadelman O, Bethke B, Burkard G. Relationships between the degree of Helicobacter pylori colonization and the degree of activity of gastritis, surface epithelium degeneration and mucus secretion. Z Gastroenterol 1995; 33: 89-93.
17. Hollander M, Wolfe DA. Non-Parametric Statistical Methods. New York: Wiley & Jones; 1973.
18. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD. et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993; 88: 1860-1864.
19. Graham DY, Opekun AR, Klein PD. Clarithromycin for the eradication of Helicobacter pylori. J Clin Gastroenterol 1993; 16: 292-294.
20. Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 4573-4580.
21. Blaser MJ, Parsonnet J. Parasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8.
22. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-1233.
23. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998; 54: 139-150.
24. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK. et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998; 114: 482-492.
25. Fan X, Crowe SE, Behar S, Gunasena H, Ye G, Haeberle H. et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med 1998; 187: 1659-1669.
26. Maassen CB, van Holten JC, Balk F, Heijne den Bak-Glashouwer MJ, Leer R, Laman JD. et al. Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet Q 1998; 20 (suppl 3): S81-S83.
27. Blum S, Rouvet M, Perruisseau G, Nesser JR, Schiffrin E. Lactic acid bacteria antagonize Gram negative enteropathogen dependent inflammation in intestinal epithelial cells in vitro. Immunologist 1998;(suppl 1):Abstract 616.
28. Haller D, Bode CH, Hammes WP, Pfeifer AMA, Schiffrin E, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000; 47: 79-87.
29. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997; 349: 1020-1022.
30. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. Infect Dis 1999; 179: 1523-1530.
31. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing H. pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-1447.
32. Hackelsberger A, Schultze V, Gunther T, von Arnim U, Manes G, Malfertheiner P. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 1998; 10: 465-468.
33. Hatlebakk JG, Berstad A. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole. Aliment Pharmacol Ther 1997; 11: 1093-1099.